Castration Resistant Prostatic Neoplasms Withdrawn Phase Trials for Enzalutamide (DB08899)

Also known as: Prostate Neoplasms, Castration-resistant / Castration-Resistant Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant

Indication	Status	Phase
DBCOND0129140 (Castration Resistant Prostatic Neoplasms)	Withdrawn	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03325127	Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study		Abiraterone (DB05812) Enzalutamide (DB08899) Radium Ra 223 dichloride (DB08913)